annual EBITDA:
-$6.30M-$134.07M(-104.93%)Summary
- As of today (May 24, 2025), RGEN annual EBITDA is -$6.30 million, with the most recent change of -$134.07 million (-104.93%) on December 31, 2024.
- During the last 3 years, RGEN annual EBITDA has fallen by -$209.57 million (-103.10%).
- RGEN annual EBITDA is now -102.32% below its all-time high of $271.29 million, reached on December 31, 2022.
Performance
RGEN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$36.38M+$34.27M(+1624.22%)Summary
- As of today (May 24, 2025), RGEN quarterly EBITDA is $36.38 million, with the most recent change of +$34.27 million (+1624.22%) on March 31, 2025.
- Over the past year, RGEN quarterly EBITDA has increased by +$6.35 million (+21.16%).
- RGEN quarterly EBITDA is now -50.61% below its all-time high of $73.66 million, reached on December 31, 2022.
Performance
RGEN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$86.61M+$6.35M(+7.92%)Summary
- As of today (May 24, 2025), RGEN TTM EBITDA is $86.61 million, with the most recent change of +$6.35 million (+7.92%) on March 31, 2025.
- Over the past year, RGEN TTM EBITDA has dropped by -$54.41 million (-38.58%).
- RGEN TTM EBITDA is now -68.77% below its all-time high of $277.31 million, reached on December 31, 2022.
Performance
RGEN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RGEN EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -104.9% | +21.2% | -38.6% |
3 y3 years | -103.1% | -48.8% | -62.4% |
5 y5 years | -111.2% | +81.5% | +44.6% |
RGEN EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -102.3% | at low | -50.6% | +1624.2% | -68.8% | +7.9% |
5 y | 5-year | -102.3% | at low | -50.6% | +1624.2% | -68.8% | +44.6% |
alltime | all time | -102.3% | +64.4% | -50.6% | +433.8% | -68.8% | +548.8% |
RGEN EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $36.38M(+1624.2%) | $86.61M(+7.9%) |
Dec 2024 | -$6.30M(-104.9%) | $2.11M(-90.1%) | $80.26M(-30.9%) |
Sep 2024 | - | $21.39M(-19.9%) | $116.11M(-8.1%) |
Jun 2024 | - | $26.73M(-11.0%) | $126.32M(-10.4%) |
Mar 2024 | - | $30.03M(-20.9%) | $141.02M(-3.0%) |
Dec 2023 | $127.77M(-52.9%) | $37.96M(+20.1%) | $145.32M(-19.7%) |
Sep 2023 | - | $31.61M(-23.7%) | $181.03M(-13.7%) |
Jun 2023 | - | $41.42M(+20.6%) | $209.88M(-12.8%) |
Mar 2023 | - | $34.33M(-53.4%) | $240.59M(-13.2%) |
Dec 2022 | $271.29M(+33.5%) | $73.66M(+21.8%) | $277.31M(+9.9%) |
Sep 2022 | - | $60.47M(-16.2%) | $252.39M(+2.6%) |
Jun 2022 | - | $72.13M(+1.5%) | $246.03M(+7.0%) |
Mar 2022 | - | $71.06M(+45.8%) | $230.02M(+13.2%) |
Dec 2021 | $203.27M(+109.4%) | $48.74M(-9.9%) | $203.27M(+13.9%) |
Sep 2021 | - | $54.10M(-3.6%) | $178.53M(+17.5%) |
Jun 2021 | - | $56.12M(+26.7%) | $151.93M(+25.2%) |
Mar 2021 | - | $44.30M(+84.6%) | $121.31M(+25.0%) |
Dec 2020 | $97.05M(+72.3%) | $24.00M(-12.7%) | $97.05M(+12.3%) |
Sep 2020 | - | $27.51M(+7.9%) | $86.44M(+24.9%) |
Jun 2020 | - | $25.50M(+27.2%) | $69.20M(+15.5%) |
Mar 2020 | - | $20.04M(+49.7%) | $59.90M(+6.4%) |
Dec 2019 | $56.31M(+28.2%) | $13.39M(+30.4%) | $56.31M(+1.5%) |
Sep 2019 | - | $10.27M(-36.6%) | $55.50M(-3.4%) |
Jun 2019 | - | $16.20M(-1.5%) | $57.42M(+14.4%) |
Mar 2019 | - | $16.45M(+30.9%) | $50.19M(+14.3%) |
Dec 2018 | $43.92M(+81.5%) | $12.57M(+3.1%) | $43.92M(+13.6%) |
Sep 2018 | - | $12.19M(+35.9%) | $38.67M(+32.6%) |
Jun 2018 | - | $8.97M(-12.0%) | $29.17M(+7.4%) |
Mar 2018 | - | $10.19M(+39.2%) | $27.15M(+12.2%) |
Dec 2017 | $24.20M(+16.4%) | $7.32M(+171.9%) | $24.20M(+12.5%) |
Sep 2017 | - | $2.69M(-61.3%) | $21.50M(-10.3%) |
Jun 2017 | - | $6.95M(-3.9%) | $23.96M(-1.5%) |
Mar 2017 | - | $7.23M(+56.3%) | $24.33M(+17.0%) |
Dec 2016 | $20.79M(+15.2%) | $4.63M(-10.1%) | $20.80M(+12.3%) |
Sep 2016 | - | $5.15M(-29.7%) | $18.52M(+1.7%) |
Jun 2016 | - | $7.33M(+98.2%) | $18.21M(+11.1%) |
Mar 2016 | - | $3.69M(+57.4%) | $16.39M(-9.2%) |
Dec 2015 | $18.05M(+18.7%) | $2.35M(-51.5%) | $18.05M(+6.1%) |
Sep 2015 | - | $4.84M(-12.0%) | $17.01M(+9.4%) |
Jun 2015 | - | $5.50M(+2.7%) | $15.55M(+9.0%) |
Mar 2015 | - | $5.36M(+309.2%) | $14.26M(-6.2%) |
Dec 2014 | $15.21M(-41.9%) | $1.31M(-61.2%) | $15.21M(-23.8%) |
Sep 2014 | - | $3.38M(-20.0%) | $19.97M(-21.7%) |
Jun 2014 | - | $4.22M(-33.1%) | $25.51M(-9.0%) |
Mar 2014 | - | $6.30M(+3.9%) | $28.03M(+7.1%) |
Dec 2013 | $26.18M(+76.4%) | $6.07M(-31.9%) | $26.18M(-4.7%) |
Sep 2013 | - | $8.92M(+32.4%) | $27.45M(+25.0%) |
Jun 2013 | - | $6.74M(+51.2%) | $21.97M(+22.7%) |
Mar 2013 | - | $4.45M(-39.4%) | $17.91M(+14.9%) |
Dec 2012 | $14.84M(-5137.9%) | $7.35M(+114.4%) | $15.59M(+89.2%) |
Sep 2012 | - | $3.43M(+28.0%) | $8.24M(+42.8%) |
Jun 2012 | - | $2.68M(+25.6%) | $5.77M(+70.9%) |
Mar 2012 | - | $2.13M(+122.5%) | $3.38M(>+9900.0%) |
Dec 2011 | -$294.50K(-117.8%) | - | - |
Sep 2011 | - | $958.30K(+236.5%) | $14.80K(-251.0%) |
Jun 2011 | - | $284.80K(-117.6%) | -$9800.00(-101.0%) |
Mar 2011 | $1.66M(-49.4%) | -$1.62M(-516.1%) | $996.50K(-27.3%) |
Dec 2010 | - | $388.60K(-58.4%) | $1.37M(+890.2%) |
Dec 2010 | $3.27M(-193.1%) | - | - |
Sep 2010 | - | $933.70K(-27.7%) | $138.40K(-109.6%) |
Jun 2010 | - | $1.29M(-203.9%) | -$1.44M(-59.0%) |
Mar 2010 | -$3.52M(-151.3%) | -$1.24M(+47.4%) | -$3.52M(-27.0%) |
Dec 2009 | - | -$843.40K(+30.0%) | -$4.82M(+28.1%) |
Sep 2009 | - | -$648.60K(-17.1%) | -$3.76M(+18.4%) |
Jun 2009 | - | -$782.60K(-69.3%) | -$3.18M(-154.7%) |
Mar 2009 | $6.85M(-81.3%) | -$2.55M(-1284.1%) | $5.81M(+23.1%) |
Dec 2008 | - | $215.00K(-439.7%) | $4.71M(+27.1%) |
Sep 2008 | - | -$63.30K(-100.8%) | $3.71M(-91.7%) |
Jun 2008 | - | $8.20M(-325.5%) | $44.74M(+21.9%) |
Mar 2008 | $36.72M(-2954.4%) | -$3.64M(+359.5%) | $36.72M(-8.6%) |
Dec 2007 | - | -$791.40K(-101.9%) | $40.16M(-1.6%) |
Sep 2007 | - | $40.97M(>+9900.0%) | $40.82M(-3758.0%) |
Jun 2007 | - | $174.20K(-188.3%) | -$1.12M(-13.2%) |
Mar 2007 | -$1.29M(+56.6%) | -$197.20K(+58.4%) | -$1.29M(-34.8%) |
Dec 2006 | - | -$124.50K(-87.1%) | -$1.97M(-9.1%) |
Sep 2006 | - | -$968.50K(<-9900.0%) | -$2.17M(+21.4%) |
Jun 2006 | - | $3900.00(-100.4%) | -$1.79M(+117.7%) |
Mar 2006 | -$821.50K(-75.9%) | -$883.00K(+173.5%) | -$821.50K(+109.1%) |
Dec 2005 | - | -$322.80K(-44.9%) | -$392.80K(-59.9%) |
Sep 2005 | - | -$586.20K(-160.4%) | -$979.00K(-50.8%) |
Jun 2005 | - | $970.50K(-313.6%) | -$1.99M(-41.6%) |
Mar 2005 | -$3.41M | -$454.30K(-50.0%) | -$3.41M(-44.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2004 | - | -$909.00K(-43.1%) | -$6.15M(-14.8%) |
Sep 2004 | - | -$1.60M(+258.6%) | -$7.22M(-5.2%) |
Jun 2004 | - | -$445.20K(-86.1%) | -$7.61M(-16.0%) |
Mar 2004 | -$9.05M(+110.9%) | -$3.20M(+62.0%) | -$9.05M(+22.0%) |
Dec 2003 | - | -$1.98M(-0.6%) | -$7.42M(+21.0%) |
Sep 2003 | - | -$1.99M(+5.2%) | -$6.13M(+18.3%) |
Jun 2003 | - | -$1.89M(+20.5%) | -$5.18M(+20.8%) |
Mar 2003 | -$4.29M(-19.3%) | -$1.57M(+128.0%) | -$4.29M(+12.5%) |
Dec 2002 | - | -$688.00K(-33.7%) | -$3.82M(-8.2%) |
Sep 2002 | - | -$1.04M(+4.0%) | -$4.16M(-11.8%) |
Jun 2002 | - | -$998.10K(-8.6%) | -$4.71M(-11.4%) |
Mar 2002 | -$5.32M(-24.6%) | -$1.09M(+6.3%) | -$5.32M(-9.1%) |
Dec 2001 | - | -$1.03M(-35.6%) | -$5.85M(-14.1%) |
Sep 2001 | - | -$1.60M(-0.5%) | -$6.81M(-1.7%) |
Jun 2001 | - | -$1.60M(-1.2%) | -$6.93M(+3.1%) |
Mar 2001 | -$7.06M(+74.7%) | -$1.62M(-18.3%) | -$6.72M(+6.1%) |
Dec 2000 | - | -$1.99M(+15.8%) | -$6.34M(+6.5%) |
Sep 2000 | - | -$1.72M(+22.9%) | -$5.95M(+21.2%) |
Jun 2000 | - | -$1.40M(+12.7%) | -$4.91M(+25.6%) |
Mar 2000 | -$4.04M(+64.4%) | -$1.24M(-22.6%) | -$3.91M(-7.5%) |
Dec 1999 | - | -$1.60M(+137.7%) | -$4.23M(+44.4%) |
Sep 1999 | - | -$673.10K(+70.0%) | -$2.93M(+19.3%) |
Jun 1999 | - | -$396.00K(-74.6%) | -$2.45M(+4.1%) |
Mar 1999 | -$2.46M(+299.4%) | -$1.56M(+418.7%) | -$2.36M(+111.3%) |
Dec 1998 | - | -$300.00K(+50.0%) | -$1.11M(+36.8%) |
Sep 1998 | - | -$200.00K(-33.3%) | -$815.00K(-10.9%) |
Jun 1998 | - | -$300.00K(-4.8%) | -$915.00K(+48.8%) |
Mar 1998 | -$615.00K(-407.5%) | -$315.00K(<-9900.0%) | -$615.00K(-715.0%) |
Dec 1997 | - | $0.00(-100.0%) | $100.00K(>+9900.0%) |
Sep 1997 | - | -$300.00K(<-9900.0%) | $0.00(-100.0%) |
Jun 1997 | - | $0.00(-100.0%) | $600.00K(+500.0%) |
Mar 1997 | $200.00K(-103.1%) | $400.00K(-500.0%) | $100.00K(-105.0%) |
Dec 1996 | - | -$100.00K(-133.3%) | -$2.00M(-48.7%) |
Sep 1996 | - | $300.00K(-160.0%) | -$3.90M(-18.8%) |
Jun 1996 | - | -$500.00K(-70.6%) | -$4.80M(-26.2%) |
Mar 1996 | -$6.40M(-63.8%) | -$1.70M(-15.0%) | -$6.50M(-5.8%) |
Dec 1995 | - | -$2.00M(+233.3%) | -$6.90M(-31.0%) |
Sep 1995 | - | -$600.00K(-72.7%) | -$10.00M(-31.5%) |
Jun 1995 | - | -$2.20M(+4.8%) | -$14.60M(-17.0%) |
Mar 1995 | -$17.70M(+5.4%) | -$2.10M(-58.8%) | -$17.60M(-8.8%) |
Dec 1994 | - | -$5.10M(-1.9%) | -$19.30M(+1.6%) |
Sep 1994 | - | -$5.20M(0.0%) | -$19.00M(+6.1%) |
Jun 1994 | - | -$5.20M(+36.8%) | -$17.90M(+4.1%) |
Mar 1994 | -$16.80M(+75.0%) | -$3.80M(-20.8%) | -$17.20M(+29.3%) |
Dec 1993 | - | -$4.80M(+17.1%) | -$13.30M(-5.0%) |
Sep 1993 | - | -$4.10M(-8.9%) | -$14.00M(+0.7%) |
Jun 1993 | - | -$4.50M(-4600.0%) | -$13.90M(+63.5%) |
Mar 1993 | -$9.60M(-17.9%) | $100.00K(-101.8%) | -$8.50M(-5.6%) |
Dec 1992 | - | -$5.50M(+37.5%) | -$9.00M(-19.6%) |
Sep 1992 | - | -$4.00M(-544.4%) | -$11.20M(+23.1%) |
Jun 1992 | - | $900.00K(-325.0%) | -$9.10M(-18.8%) |
Mar 1992 | -$11.70M(+58.1%) | -$400.00K(-94.8%) | -$11.20M(-23.8%) |
Dec 1991 | - | -$7.70M(+305.3%) | -$14.70M(+79.3%) |
Sep 1991 | - | -$1.90M(+58.3%) | -$8.20M(+9.3%) |
Jun 1991 | - | -$1.20M(-69.2%) | -$7.50M(+1.4%) |
Mar 1991 | -$7.40M(+335.3%) | -$3.90M(+225.0%) | -$7.40M(-48.6%) |
Dec 1990 | - | -$1.20M(0.0%) | -$14.40M(+50.0%) |
Sep 1990 | - | -$1.20M(+9.1%) | -$9.60M(+68.4%) |
Jun 1990 | - | -$1.10M(-89.9%) | -$5.70M(+171.4%) |
Mar 1990 | -$1.70M(-39.3%) | -$10.90M(-402.8%) | -$2.10M(+133.3%) |
Dec 1989 | - | $3.60M(+33.3%) | -$900.00K(-50.0%) |
Sep 1989 | - | $2.70M(+8.0%) | -$1.80M(-35.7%) |
Jun 1989 | - | $2.50M(-125.8%) | -$2.80M(-20.0%) |
Mar 1989 | -$2.80M(+366.7%) | -$9.70M(-459.3%) | -$3.50M(+66.7%) |
Dec 1988 | - | $2.70M(+58.8%) | -$2.10M(-40.0%) |
Sep 1988 | - | $1.70M(-5.6%) | -$3.50M(0.0%) |
Jun 1988 | - | $1.80M(-121.7%) | -$3.50M(+3400.0%) |
Mar 1988 | -$600.00K(-86.0%) | -$8.30M(-738.5%) | -$100.00K(-112.5%) |
Dec 1987 | - | $1.30M(-23.5%) | $800.00K(+60.0%) |
Sep 1987 | - | $1.70M(-67.3%) | $500.00K(-266.7%) |
Jun 1987 | - | $5.20M(-170.3%) | -$300.00K(-93.8%) |
Mar 1987 | -$4.30M(+115.0%) | -$7.40M(-840.0%) | -$4.80M(+84.6%) |
Dec 1986 | - | $1.00M(+11.1%) | -$2.60M(-3.7%) |
Sep 1986 | - | $900.00K(+28.6%) | -$2.70M(0.0%) |
Jun 1986 | - | $700.00K(-113.5%) | -$2.70M(+8.0%) |
Mar 1986 | -$2.00M(+17.6%) | -$5.20M(-677.8%) | -$2.50M(+127.3%) |
Dec 1985 | - | $900.00K(0.0%) | -$1.10M(-21.4%) |
Sep 1985 | - | $900.00K(0.0%) | -$1.40M(-17.6%) |
Jun 1985 | - | $900.00K(-123.7%) | -$1.70M(-15.0%) |
Mar 1985 | -$1.70M | -$3.80M(-733.3%) | -$2.00M(-211.1%) |
Dec 1984 | - | $600.00K(0.0%) | $1.80M(+50.0%) |
Sep 1984 | - | $600.00K(0.0%) | $1.20M(+100.0%) |
Jun 1984 | - | $600.00K | $600.00K |
FAQ
- What is Repligen annual EBITDA?
- What is the all time high annual EBITDA for Repligen?
- What is Repligen annual EBITDA year-on-year change?
- What is Repligen quarterly EBITDA?
- What is the all time high quarterly EBITDA for Repligen?
- What is Repligen quarterly EBITDA year-on-year change?
- What is Repligen TTM EBITDA?
- What is the all time high TTM EBITDA for Repligen?
- What is Repligen TTM EBITDA year-on-year change?
What is Repligen annual EBITDA?
The current annual EBITDA of RGEN is -$6.30M
What is the all time high annual EBITDA for Repligen?
Repligen all-time high annual EBITDA is $271.29M
What is Repligen annual EBITDA year-on-year change?
Over the past year, RGEN annual EBITDA has changed by -$134.07M (-104.93%)
What is Repligen quarterly EBITDA?
The current quarterly EBITDA of RGEN is $36.38M
What is the all time high quarterly EBITDA for Repligen?
Repligen all-time high quarterly EBITDA is $73.66M
What is Repligen quarterly EBITDA year-on-year change?
Over the past year, RGEN quarterly EBITDA has changed by +$6.35M (+21.16%)
What is Repligen TTM EBITDA?
The current TTM EBITDA of RGEN is $86.61M
What is the all time high TTM EBITDA for Repligen?
Repligen all-time high TTM EBITDA is $277.31M
What is Repligen TTM EBITDA year-on-year change?
Over the past year, RGEN TTM EBITDA has changed by -$54.41M (-38.58%)